Breast Density Awareness by Acker, Alyssa
Role of Mammography in Breast 
Imaging
v Mammography is optimal for comparing the 
ratio of fat to fibroglandular tissue of the breast. 
It is considered the best screening tool for 
breast composition and abnormalities. 
Mammography requires low-dose ionizing 
radiation in order to evaluate the breast tissue  
and is cost efficient. Breast tissue with higher 
density are more difficult to penetrate creating 
more to detect abnormalities or masses. 
(Biomarker, 2015). Digital breast tomosynthesis, 
or 3D mammography, has increased the 
sensitivity of detection of subtle findings. 
Tomosynthesis uses an electronic detector 
system to obtain multiple projection images 
which are synthesized by the computer to create 
thin slices of the breast tissue. This allows the 
radiologist the ability to scroll through the 
images, reducing tissue overlap and providing 
earlier detection of abnormalities that may be 
masked during conventional mammography 
(Hooley, 2017). Mammography is often 
complimented by ultrasound and MRI to further 
characterize areas of suspicion or confirm the 
composition of the lesion.
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Mammography Limitations
v Mammographic sensitivity decreases with 
increasing breast density. This is primarily due to 
the masking effect of the fibroglandular breast 
tissue, which can obscure an underlying 
malignancy (Zhao, 2015). 
v False-negative results. Overall, screening 
mammograms do not find abut 1 in every 5 
breast malignancies (Zhao, 2015). 
v Mammography cannot determine the exact size 
and location of an abnormality (Zhao, 2015).
Role of Sonography in Breast 
Imaging
v Breast Sonography (ultrasound) is an 
imaging modality which uses sound waves to 
produce images of the internal structures of the 
breast. Ultrasound is currently the most widely 
utilized supplemental imaging modality 
appropriate for women with dense breasts and 
intermediate or average risk, as well as women 
with a very high-risk (Moothathu, 2017). 
Ultrasound can better differentiate fluid filled 
lesions from solid tissue lesions and document 
characteristics associated with benign versus 
malignant lesions. Advancing technology and 
automated breast ultrasound system (ABUS) is 
a more current technology standardizing breast 
ultrasound imaging of the whole breast, reduces 
operator dependency, and allows physicians to 
school through all breast tissue. Breast 
ultrasound is widely available, well tolerated by 
patients, relatively inexpensive, and can detect 
small, less than 1 cm in size, invasive 
mammographically occult malignancies 
(Moothathu, 2017).  
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Sonography Limitations
v Not sensitive to microcalcifications. 
Microcalcifications may be present on the 
mammographic images but not the ultrasound 
images (Kawamura, 2018). 
v Conventional sonography is user dependent, if 
the sonographer is to miss an area while 
scanning, a potential abnormality could be 
missed (Kawamura, 2018). 
v Length of time required to scan an entire 
breast. More commonly only the suspicious 
quadrant or area of the breast is scanned 
rather than the entire breast (Kawamura, 
2018). 
v ABUS is available and less user dependent but 
it is underutilized. 
Introduction
v Breast density can be defined as, “a measure 
used to describe the proportion of 
fibroglandular tissue in a woman’s breast 
depicted on a digital mammogram” (Mohamed 
2018, pg. 315).
v In 1992, the Mammography Quality Standards 
Act (MSQA) was enacted to ensure that all 
women would have access to quality 
mammography for the detection of breast 
cancer in its earliest, most treatable stages 
(Center, About the Mammography Program, 
2018). 
v For the past 25 years, the Mammography 
Quality Standards Act has required 
mammography facilities to send each patient a 
written summary of the mammography report in 
lay terms. The MQSA requires that the written 
summary must be sent within 30 days of the 
mammogram and if the patient’s mammogram 
is interpreted as “Suspicious” or “Highly 
Suggestive of Malignancy”, the facility must 
make reasonable attempts to communicate 
these results to the patient and the referring 
healthcare provider (Center, Direct-To-Patient 
Mammogram Results, 2018). 
v In additional to the MQSA requirements, the 
Breast Density Notification Law was created, 
with 38 states passing the law since January 
2020. 
v The Breast Density Notification Legislature 
states that within the written summary of the 
mammogram results, the patient’s breast 
density using the American College of 
Radiology categories must be included for 
patients to be aware of their own density 
(Department, 2019). 
v Although state legislature has increased 
women’s knowledge on the topic of breast 
density and the risks associated with it, it has 
also brought on challenges for physicians. 
Primary physicians need education on best 
practices for management and when the patient 
should be referred for ultrasound imaging. 
v Research has show that women with a higher 
breast density are at an increased risk for 
developing breast cancer (Moothathu, 2017). 
v A limitation associated with mammography is 
that microcalcifications, which are often the 
findings suspicious for early diagnosis of breast 
malignancies, can be obscured by higher breast 
density (Moothathu, 2017). 
Categories of Breast Density
v The BI-RADS mammographic breast density 
criteria include four qualitative categories of 
breast density:
1. Almost entirely fatty
• Approximately 10% of women
2. Scattered areas of fibroglanduar density
• Approximately 40% of women
3. Heterogeneously dense
• Approximately 40% of women
4. Extremely dense




v Due to the increased risk of breast cancer 
associated with breast density, it is essential 
women are knowledgeable on the topic of 
breast density. It is also important that 
physicians are informing patients on their 
breast density category and referring them for 
additional imaging exams if necessary. 
Although there are limitations associated with 
both mammography and breast sonography, 
using supplemental screening tools is the best 
way to evaluate a potential breast abnormality. 
According to a study performed in 2018, 90% 
of the women agreed that they would prefer to 
know their breast tissue type. It also showed 
that having a breast density reporting law 
enacted by the state increased the likelihood 
that a women learned their breast tissue type 
from a mammogram results letter and health 
care providers spoke with women about 
receiving supplemental screening (Cappello, 
2019). If all states were to pass the Breast 
Density Notification Legislature, more women 
would become informed on the risks 
associated with breast density. Breast density 
awareness could be improved because of the 
enactment of the Breast Density Notification 
Legislature, therefore reducing the number of 
women affected by undetected early staged 
breast cancer. 
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